WEBSTER BANK, N. A. - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,063 filers reported holding BAXTER INTL INC in Q3 2018. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
WEBSTER BANK, N. A. ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$25,663
-17.2%
6800.0%0.00%
-25.0%
Q2 2023$30,981
+12.3%
6800.0%0.00%0.0%
Q1 2023$27,581
+68852.5%
680
-12.8%
0.00%
-20.0%
Q4 2022$40
-99.9%
7800.0%0.01%
-16.7%
Q3 2022$42,000
-17.6%
780
-2.0%
0.01%
-14.3%
Q2 2022$51,000
-17.7%
7960.0%0.01%0.0%
Q1 2022$62,000
-12.7%
796
-2.7%
0.01%0.0%
Q4 2021$71,000
+7.6%
8180.0%0.01%0.0%
Q3 2021$66,0000.0%8180.0%0.01%0.0%
Q2 2021$66,000
-4.3%
8180.0%0.01%
-12.5%
Q1 2021$69,000
-1.4%
818
-6.8%
0.01%0.0%
Q4 2020$70,000
-1.4%
8780.0%0.01%
-11.1%
Q3 2020$71,000
-12.3%
878
-6.4%
0.01%
-18.2%
Q2 2020$81,000
+6.6%
9380.0%0.01%
-15.4%
Q1 2020$76,000
-5.0%
938
-2.3%
0.01%
+30.0%
Q4 2019$80,000
-4.8%
9600.0%0.01%
-9.1%
Q3 2019$84,000
+7.7%
9600.0%0.01%0.0%
Q2 2019$78,000
+39.3%
960
+40.1%
0.01%
+37.5%
Q1 2019$56,000
+16.7%
685
-5.5%
0.01%0.0%
Q4 2018$48,000
-52.5%
725
-44.2%
0.01%
-42.9%
Q3 2018$101,000
+5.2%
1,3000.0%0.01%0.0%
Q2 2018$96,000
+10.3%
1,300
-1.9%
0.01%
+7.7%
Q1 2018$87,000
+2.4%
1,3250.0%0.01%
+8.3%
Q4 2017$85,000
+2.4%
1,3250.0%0.01%0.0%
Q3 2017$83,000
-8.8%
1,325
-11.8%
0.01%
-7.7%
Q2 2017$91,000
+16.7%
1,5030.0%0.01%
+8.3%
Q1 2017$78,000
+18.2%
1,5030.0%0.01%
+20.0%
Q4 2016$66,000
-88.1%
1,503
-80.0%
0.01%
-87.0%
Q1 2014$554,000
+5.7%
7,5300.0%0.08%
+5.5%
Q4 2013$524,000
-14.5%
7,530
-19.3%
0.07%
-22.3%
Q3 2013$613,000
-5.4%
9,330
-0.3%
0.09%
+14.6%
Q2 2013$648,0009,3550.08%
Other shareholders
BAXTER INTL INC shareholders Q3 2018
NameSharesValueWeighting ↓
Tavio Capital LLC 68,405$5,890,0007.81%
Iron Triangle Partners LP 330,000$28,413,0007.16%
Veritas Asset Management LLP 8,942,428$769,943,0005.64%
TSFG, LLC 93,405$8,042,0005.31%
GENERATION INVESTMENT MANAGEMENT LLP 10,606,094$913,185,0005.27%
Third Point 4,000,000$344,400,0004.72%
Avidity Partners Management LP 800,900$68,957,0004.42%
Palmer Knight Co 62,275$5,362,0004.17%
Eos Focused Equity Management, L.P. 36,786$3,167,0003.70%
Dundas Partners LLP 196,133$16,887,0003.69%
View complete list of BAXTER INTL INC shareholders